Bounded university collaboration

Choose one work package, not an entire platform

Each package begins with an intended use, frozen artifacts, explicit partner effort, a validation or verification domain, decision rights, and acceptance criteria that permit an unfavorable result.

No institution, investigator, reviewer, dataset, approval, endorsement, or collaboration is claimed here. These are ready-to-negotiate protocols; external participation remains an open gate.

Recommended first ask

WP1 — Nuclear Data and Reactivity Reproduction

Research question: Can an independent team reproduce selected p–¹¹B reactivity results from versioned data and equations, inside explicit domains and tolerances?

HBF contributes
  • Runnable FusionSim benchmark and source/model registry
  • RunSpec/ResultSpec contracts, fixtures, tolerances, hashes, and release container
  • Source transcription notes and discrepancy log
  • Engineering support for reproduction and archive packaging
Partner contribution
  • Independent source interpretation and implementation
  • Review of intended use, source domain, transformations, and uncertainty
  • Blind comparison before discrepancy resolution
  • Signed result/review record scoped to the exact immutable artifact
WeeksActivityDeliverable
1–2Freeze intended use, source set, protocol, and toleranceSigned reproduction plan
3–4Independent source transcription and pedigree reviewReviewed source records
5–6Checkpoint and curve reproductionIndependent result bundle
7–8Domain, sensitivity, and uncertainty reviewUQ report
9–10Resolve differences without erasing themIssue and decision log
11–12Freeze and archiveBenchmark report and immutable package

Acceptance: exact source versions and transformations reproduce; independent results are compared before tuning; all discrepancies remain visible; the validation/reproduction domain is explicit; conclusions do not extrapolate beyond it.

Alternative first ask

WP2 — Alpha Diagnostics and CR-39 Validation

Research question: How accurately and repeatably can one frozen AlphaTrack model count declared real CR-39 track classes under one controlled acquisition protocol?

Dependencies
  • Licensed, partner-controlled real CR-39 data
  • Plate-level split with no plate or batch leakage
  • Independent expert annotation and adjudication
  • Statistician-reviewed power/precision and abstention plan
  • Local-first processing, custody, retention, and deletion terms
12-week output
  • Weeks 1–3: intended use, acquisition protocol, classes, shift risks
  • Weeks 4–6: annotation study, precision planning, preregistration, freeze
  • Weeks 7–9: blinded acquisition, annotation, and sealed evaluation
  • Weeks 10–11: unblind, primary and failure/subgroup analysis
  • Week 12: archive a positive, negative, or inconclusive report

Acceptance: no plate/batch leakage; prespecified primary metric and interval; human and model disagreement remains auditable; all deviations and abstentions are reported; the result is released whether favorable or unfavorable; any claim is limited to the tested detector and acquisition domain.

Supporting option

WP3 — Reduced Plasma and Orbit Model Verification

Research question: Does one tightly defined HBF orbit model converge and agree with analytic cases and an independent solver for the same mathematical problem?

Frozen scope
  • One analytic field model and coordinate convention
  • One integrator configuration and error metric
  • Manufactured/analytic cases and refinement sequence
  • Finite-window and right-censoring semantics
Acceptance
  • Analytic fixtures pass
  • Declared refinement behavior is demonstrated
  • Partner implementation is independent
  • Blind comparison precedes reconciliation
  • Disagreement and applicable domain are published

Governance before data

Terms that must be agreed

Scope, staffing, data and code licenses, publication timing, authorship, foreground/background IP, confidentiality limits, safety responsibility, conflict disclosure, use of names/logos, retention and deletion, security incidents, and the right to publish negative results.